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Abstract 
Background: Socioeconomic status (SES) has been focused on as a key determinant of the incidence of cancer, 
cancer stage at diagnosis as well as treatment choices in western countries. However, to the authors’ knowledge, little 
work has been done concerning the relationship of SES and esophageal cancer in China.
Methods: Patients diagnosed with primary esophageal cancer from January to December 2007 in Qilu hospital were 
included. Socioeconomic status was determined by a questionnaire including religion, years of schooling and high 
education, place of residence, occupation, annual household income, and insurance.
Results: A total of 238 cases were collected in this study. Linear-by-linear association testing revealed that health-
care delay was significantly associated with SES (P = 0.009). Multivariable logistic regression analysis revealed that 
increased health-care delay (>2 months) was more frequently observed in patients with lower SES (OR 2.271; 95% CI 
1.069–4.853). Patients diagnosed at TNM I and II were more frequently in higher SES groups (P = 0.017). The associa-
tion test was statistically significant for undergoing surgical resection only (P = 0.015) and chemotherapy (P = 0.015). 
Multivariable logistic regression analysis revealed that surgical resection only was less performed in higher SES group 
compared with lower SES group (OR 0.372; 95% CI 0.188–0.734). For chemotherapy, higher SES patients had a three-
fold higher likelihood compared with lower SES group (OR 3.042; 95% CI 1.335–6.928).
Conclusion: Socioeconomic status was found to be associated with health-care delay, tumor stage and treatment 
modalities in esophageal cancer.
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Background
Esophageal cancer is the eighth most common cancer 
and the sixth leading cause of cancer deaths worldwide. 
Patients with esophageal cancer have a poor prognosis, 
and the 5-year overall survival rate is only 15–20% [1]. 
One of the reasons that lead to this dismal prognosis is 
diagnosed at a relatively advanced stage of this malig-
nancy, because the beginning symptoms are ignored by 
patients and delay between the first symptom recognition 
and the first medical consultation exists [2]. When peo-
ple realize the discomfort feelings are severe enough to a 
hospital visit, many patients have missed their best treat-
ment time. For esophageal cancer treatment, surgery is 
the first option. Besides, radiotherapy and chemotherapy 
are also available [3]. Treatment regimens are differ-
ent based on infiltrated depth of primary tumors, lymph 
node metastasis status, and many other factors.
Socioeconomic status (SES) is found to be closely 
related with various cancers, such as hepatocellular can-
cer, breast cancer, colorectal cancer, and so on [4–8]. 
These studies mainly focus on the association between 
SES and the incidence of cancer as well as mortality in 
cancer. Previous study has shown socioeconomic factors 
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have profound influence on delayed reporting and late-
stage presentation of late rectal sequelae among Chi-
nese cervical cancer patients [9]. Delayed reporting and 
late-stage presentation of late rectal sequelae are more 
prevalent among Chinese cervical cancer patients with 
low education or poor financial status. It has also been 
reported that SES is an important factor in treatment 
choice of cancer. In breast cancer, patients with a higher 
SES underwent a more appropriate treatment modality 
compared to patients with a lower SES [10].
In esophageal cancer, some studies have shown a strong 
association of SES with ESCC in cancer incidence [11–
13], staging and treatment decision [14, 15]. However, to 
our knowledge, little information is available concerning 
the association between socioeconomic status and delay 
from symptom recognition to health care. Therefore, 
in the current study, we aimed to assess the association 
between SES and delay to health care in esophageal can-
cer. Meanwhile, we investigated whether SES was corre-
lated with tumor stage and treatment modalities among 
esophageal cancer patients.
Methods
Study population
We searched all of the esophageal cancer patients in the 
department of thoracic surgery at Qilu hospital from 
January to December 2007. Patients were included in this 
study if they had histologic documentation. A total of 248 
patients were collected in the present study.
Data collection
Patients’ characteristics were obtained from hospital 
electronic recording system, such as gender, tumor loca-
tion, tumor stage, histological type, and so on. Tumor 
localization was categorized into four groups by anatomic 
subsites: lower thoracic, middle thoracic, upper thoracic, 
or cervical subsite of the esophagus. Tumor stage was 
based on the clinical TNM classification, according to 
the sixth and seventh International Union against Cancer 
editions, as appropriate.
Socioeconomic status of the subjects was defined by 
religion, years of schooling and high education, place of 
residence (rural or urban), occupation, annual house-
hold income, and insurance. We collected the informa-
tion concerning the above covariates using a standard 
questionnaire. After we got the scale of the covariates, 
SES was determined on a scale of 1–9 including income, 
dwelling area in meters squared per person, and years of 
schooling and higher education, tax payments [16]. We 
regrouped SES into low (1–3), medium (4–6), and high 
(6–9) categories.
Dates when the patient first experienced the symp-
toms and the first medical consultation were recorded. 
Health-care delay was defined as the time interval 
between the first symptom appearance and first contact-
ing the health-care system. According to the mean value 
of this time interval, we divided the patients into two 
groups: those who sought health care within 2  months 
or less and those who sought medical care more than 
2  months after patients first experienced the symptoms 
that led to diagnosis.
Treatment modalities in this study included resection, 
postoperative radiotherapy, postoperative chemotherapy, 
a combination of radiotherapy and chemotherapy after 
resection. For each subject, it was determined whether 
esophageal resection, chemotherapy, or radiotherapy had 
been performed.
Statistical analyses
Linear-by-linear association testing (Chi square testing) 
was used to assess associations between SES and health-
care delay, tumor staging and treatment modality. Mul-
tivariable logistic regression was used to estimate odds 
ratios (ORs) with 95% confidence intervals (CI) and P val-
ues. All P values were based on two-sided tests of signifi-
cance. P < 0.05 were regarded as statistically significant. 
Analyses were performed using SPSS statistical software 
(version 20.0; SPSS Inc, Chicago, IL, USA).
Results
Patient characteristics
The current study consisted of 248 patients with a mean 
age of 60.5 years old. The majority of patients was male 
(81.9%). Of these patients, 207 (87%) were diagnosed 
with squamous cell carcinoma (ESCC) while the remain-
ing had a non-squamous cell carcinoma. 27.3% of the 
patients reported a delay of more than 2  months. The 
characteristics of the study population and their delayed 
interval are shown in Additional file 1: Table S1.
Health‑care delay
Additional file 2: Table S2 shows the number of patients 
with health-care delay per SES group. We found a lower 
percentage of esophageal cancer patients with more than 
2 months delay in higher SES group (P = 0.009). In Addi-
tional file 3: Table S3, the result of the multivariable logis-
tic regression analysis is shown. With adjustment for age, 
gender, tumor location, T stage, N stage, and TNM stage, 
analysis of the association between SES and health-care 
delay revealed that shorter delay (≤2  months) was sig-
nificantly associated with a higher SES (OR 2.271; 95% CI 
1.069–4.853; P = 0.034).
Tumor stage
Additional file  2: Table  S2 presents the number of 
patients with T, N and TNM stages per SES group. The 
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linear-by-linear association test was not significant for T 
(P = 0.637), N (P = 0.788) and TNM stage (P = 0.896). 
However, after we combined TNM I and II groups, The 
linear-by-linear association test was statistically signifi-
cant (P =  0.017). The results of the multivariable logis-
tic regression analyses are shown in Additional file  4: 
Table  S4. It was found that the adjusted ORs of tumor 
stage were not statistically significant. The adjustment 
factors included age, gender, tumor location, and tumor 
histology.
Treatment modality
Additional file 2: Table S2 also shows the result of linear-
by-linear association between SES and treatment modali-
ties. The association test was statistically significant for 
undergoing surgical resection only (P  =  0.015), show-
ing that surgical resection only were less performed in 
patients with a higher SES. The association test was also 
statistically significant for undergoing chemotherapy 
(P  =  0.015), demonstrating that chemotherapy were 
more performed in patients with a higher SES. The P val-
ues for radiotherapy (P = 0.137) and chemoradiotherapy 
(P = 0.107) did not reach the significant level.
Additional file 5: Table S5 shows the results of the mul-
tivariable logistic regression analyses. For surgical resec-
tion only, the adjusted OR was statistically significant 
(OR 0.372; 95% CI 0.188–0.734; P  =  0.004) with con-
founding factors including age, gender, tumor location, 
tumor histology, and TNM stage. In other words, the 
likelihood that a surgical resection only was performed 
in higher SES group declined by 62.8% compared with 
lower SES group. For chemotherapy, the adjusted OR was 
statistically significant (OR 3.042; 95% CI 1.335–6.928; 
P  =  0.008), meaning that compared with lower SES 
group, patients with a higher SES had a three-fold higher 
likelihood of undergoing chemotherapy. For radiother-
apy and chemoradiotherapy, the adjusted ORs were not 
statistically significant (radiotherapy: OR 1.951; 95% CI 
0.972–3.916; P  =  0.060; chemoradiotherapy: OR 3.098; 
95% CI 0.972–9.871; P = 0.056).
Additional file  6: Table  S6 shows the result of linear-
by-linear association between tumor stage and treatment 
modalities. The association test was statistically signifi-
cant for undergoing surgical resection only (P =  0.007) 
and chemotherapy (P =  0.046). The P values for radio-
therapy (P = 0.162) and chemoradiotherapy (P = 0.155) 
did not reach the significant level.
Discussion
In the present study, we determined the role of SES 
on delay access to health-care system, tumor stage, 
and treatment choice in esophageal cancer patients. 
We found that patients with a higher SES had shorter 
health-care delay, were less likely to be diagnosed at a late 
stage, and had a higher likelihood of undergoing chemo-
therapy after surgical resection.
In this study, ESCC accounts for 87.0% and this per-
centage is line with incidence rate of ESCC in China 
where the predominant histological type is squamous cell 
carcinoma. There is strong evidence to support an asso-
ciation between histological type and SES in esophageal 
cancer. With increasing SES, the incidence of squamous 
cell carcinoma declines and that of adenocarcinoma 
increases [12]. The result of our study is not consistent 
with previous studies. We found no association between 
the incidence of ESCC and SES in the present study 
(P  =  0.642). The incidence difference can be explained 
that smoking habits and alcohol consumption are more 
common in lower SES patients, whereas gastroesopha-
geal reflux (GERD) are more prominent in patients with 
a higher SES. However, in China, healthy habits do not 
develop with wealth increasing. Smoking, alcohol con-
sumption and stay up all night are common in modern 
people with different SES. That may be why there is no 
correlation between SES and squamous cell carcinoma 
incidence.
Association between SES and delay access to health 
care has been shown in cervical cancer, lung can-
cer, breast cancer before [9, 17–19]. Low SES patients 
undergo a longer time interval between first symptom 
recognition and first medical consultation. Our result 
is line with findings in the previous literature. Previous 
studies about association between SES and esophageal 
cancer mainly focus on one single factor for SES, such as 
educational level, annual income, and so on. In this study, 
we combined the main factors affecting SES and got a 
SES scale to analyze. So our study adjusted the main SES 
factors, and the result could reflect SES more exactly.
For the explanation, as reported before, low education 
is strongly related to poor health literacy and low or lim-
ited health literacy is an important risk factor of worse 
health outcomes [20]. Patients with low education tend 
to have low awareness of esophageal cancer, therefore 
they ignore the symptom and is less likely to seek pre-
ventive screening measures. Patients with a higher SES, 
usually with a higher income, seek medical care with less 
hesitation. Patients with a lower SES have worse financial 
support and less ability to afford medical care, thus the 
time delay is prolonged.
Urban–rural divide is still great nowadays in China. 
High SES group covers more individuals of urban areas. 
Medical consultation in urban areas is more conveni-
ent. They may have more access to medical services than 
residents of rural areas, which would in turn make them 
more likely to seek prompt medical care for any health 
problems [21]. Moreover, health insurances for urban 
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areas offer a higher ratio of reimbursement. These differ-
ences may contribute to disparities in health-care delay.
It has previously been shown that patients with a lower 
SES are diagnosed at a more advanced stage because 
of unequally access to health care and increased delay 
between symptom awareness and visiting primary health 
care in gastrointestinal tumors [22]. The result of corre-
lation between SES and stage in our study is consistent 
with previous studies. Patients with a higher SES were 
more likely to be diagnosed at a less advanced stage. It 
can be explained by the fact that health care is not equally 
accessible in China, and people with a higher SES seek 
health care more conveniently. Furthermore, as we men-
tioned above, higher SES group tend to have a shorter 
time interval between symptom recognition and visiting 
primary medical care.
A study conducted in The Netherlands has shown that 
no statistically significant correlation is found between 
SES and TNM stage, because health insurance covers 
almost all people in The Netherlands, resulting in a simi-
lar access to health care faculties for all income groups 
[15]. Apparently this situation was not suitable for China. 
Meantime this study indicates that access to health care 
is an important factor for stage difference between SES 
groups from another perspective.
Differences in treatment modalities have been reported 
before [14, 15, 23]. It has been shown in esophageal can-
cer that resection and chemotherapy are more often per-
formed with increasing SES and no correlation is found 
between SES and radiation therapy [15]. Reasons for this 
association are summarized in this paper, including dif-
ferences in attitudes toward invasive procedures, disease 
severity, access to care [24], differences in undergoing 
staging procedures [25], and issues related to health 
insurance [26]. Our results are in agreement with find-
ings from previous studies. We found that patients with 
a higher SES were less likely to receive surgical resection 
only and more likely to undergo chemotherapy after sur-
gery. To explain the differences in treatment modalities 
between different SES classes, educational level must be 
taken into consideration. With more years of education, 
patients show better cognition of the malignant disease. 
Besides, higher SES patients have more advanced health 
insurance and primary medical care system. Compared 
with lower SES group, these patients have lighter eco-
nomic burden. People with higher SES often have offi-
cial jobs and the employment departments offer regular 
physical examinations  of the  staff. So no wonder the 
signs and symptoms in this group are recognized ear-
lier. And the optimal opportunity for treatment is not 
missed. Thus the choice of treatment can be better. 
This might well suggest that patients with a higher SES 
are more eager to receive chemotherapy to overcome 
the malignant disease they are suffering from. But in 
the mind of patients with a lower SES, cancer is such a 
kind of disease that cannot be improved at all with high 
treatment cost. Hence they give up before any treat-
ment options. Besides, socioeconomically disadvantaged 
patients experience barriers to effective treatment, such 
as inadequate insurance coverage, financial burden, and 
access to effective therapy [27]. Refusal of radiation ther-
apy may help to explain that no correlation between SES 
and radiotherapy were found, because decreasing annual 
income and Asian American race are associated with 
refusal of radiation [28].
TNM staging system is common used in esophageal 
cancer and we found significant correlation between 
TNM staging and treatment modalities. The results 
showed that surgery only and surgery plus postoperative 
chemotherapy have significant correlation with tumor 
staging (P  =0.007, P  =  0.046). The reasons under this 
correlation may be individual index, including different 
access to medical care, different realization to treatment 
modalities and issues related to health insurance [24, 26]. 
Patients with early stage tend to have convenient access 
to medical care or more aware about their health condi-
tions. As we have discussed before, patients with better 
SES often have sound health care system, or else they do 
not have heavy economic burden, so they come to hos-
pital without hesitancy. And stage of tumor is the deter-
mining factor for treatment choice, patients diagnosed at 
an earlier stage can receive prompt therapy with optimal 
timing.
Our study has several limitations. First, the sample 
size was small since there were only 238 cases included 
and only a single institution was investigated. For socio-
economic study, the number was relatively small. Mul-
ticenter, large sample clinical analysis is required for 
further study. Second, the calculation method of SES 
was self-designed because of the absence of a recognized 
standard for SES measures in China. Third, the included 
patients were from the department of thoracic surgery, 
and all of them underwent operation for treatment. So 
the differences in treatment modalities mainly focus on 
additional treatment after surgery. The effect of SES on 
patients receiving surgery or not cannot be researched 
from this study.
Conclusion
We identified an association between SES and delay 
access to health-care system. Additionally, SES was found 
to be involved with tumor stage and treatment choice in 
esophageal cancer. Patients with a higher SES were more 
likely to undergo chemotherapy after surgery. Further 
studies are needed to provide more insight in the causes 
of these differences.
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